Clovis Oncology Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Clovis Oncology Inc inventory turnover ratio, the Clovis Oncology Inc 's ability to sell and replace its inventory in the third quarter 2022, sequentially increased to 2.39 in the third quarter 2022, a new company high. Average inventory processing period, for the Clovis Oncology Inc in Sep 30 2022 quarter, has decreased to 153 days, compare to 163 days, in the Jun 30 2022 quarter.

Within Healthcare sector 224 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the III Quarter 2022, to 1438, from total ranking in the second quarter 2022 at 1639.

CLVS Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Clovis Oncology Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CLVS Inventory Turnover Ratio	(Sep 30 2022) III. Quarter	(Jun 30 2022) II. Quarter	(Mar 31 2022) I. Quarter	(Dec 31 2021) IV. Quarter	(Sep 30 2021) III. Quarter
Y / Y Inventory Growth	-33.91 %	-47.06 %	-34.57 %	-55.43 %	-29.84 %
Y / Y Cost of Sales Growth	-14.59 %	-5.09 %	-2.39 %	-11.47 %	0.81 %
Inventory Turnover Ratio (TTM)	2.39	2.24	1.89	1.71	1.45
CLVS's Total Ranking	# 1438	# 1639	# 1478	# 1821	# 1776
Average inventory processing period	153	163	193	213	251
Seq. Inventory Growth	-13.7 %	-8.77 %	5.96 %	-20.77 %	-30.87 %
Seq. Cost of Sales Growth	-7.71 %	-2.45 %	-3.78 %	-1.4 %	2.56 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 76
Healthcare Sector	# 225
Overall Market	# 1438

Inventory Turnover Ratio Statistics
High	Average	Low
2.39	1.11	0.13
(Sep 30 2022)		(Dec 31 2017)

CLVS Company Profile >> Back to CLVS Efficiency Comparisons >> Compare CLVS Inventory Turnover Ratio to its Competitors

Financial Statements
Clovis Oncology Inc 's Inventories	$ 11 Millions	Visit CLVS's Balance sheet
Clovis Oncology Inc 's Cost of Revenues TTM	$ 32 Millions	Visit CLVS's Income Statement
What are CLVS's Sales?		Visit CLVS's Sales by Segment

Other Inventory Turnover Ratios
Clovis Oncology Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
CLVS's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for CLVS's Competitors
Inventory Turnover Ratio for CLVS's Suppliers
Inventory Turnover Ratio for CLVS's Customers

You may also want to know
CLVS's Sales Growth Rates	CLVS's Pe Price to earnings ratio	CLVS's Receivables Turnover Ratio	CLVS's Stock Quote
CLVS's Net Income Growth Rates	CLVS's Ps Price to Sales ratio	CLVS's Sales per Employee	CLVS's Asset Turnover Ratio
CLVS's Net Margin	CLVS's Pb Price to Book ratio	CLVS's Financial Strength Ratios	CLVS's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2022, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Sep 30 2022	Inventories at quarter ending Sep 30 2022
Puma Biotechnology Inc	7.57	$ 50.153 Millions	$ 7 Millions
National Vision Holdings Inc	7.33	$ 921.089 Millions	$ 126 Millions
Societal Cdmo Inc	7.23	$ 65.345 Millions	$ 9 Millions
Kewaunee Scientific Corporation	7.08	$ 165.189 Millions	$ 23 Millions
Sensus Healthcare Inc	7.05	$ 14.318 Millions	$ 2 Millions
Neptune Wellness Solutions Inc	7.03	$ 50.927 Millions	$ 7 Millions
Bionexus Gene Lab Corp	6.92	$ 10.002 Millions	$ 1 Millions
Advanced Container Technologies Inc	6.57	$ 2.767 Millions	$ 0 Millions
Adm Tronics Unlimited Inc	6.53	$ 2.170 Millions	$ 0 Millions
Genedx Holdings Corp	6.28	$ 244.375 Millions	$ 39 Millions
Hims and Hers Health Inc	6.26	$ 105.929 Millions	$ 17 Millions
Cryoport inc	6.16	$ 132.651 Millions	$ 22 Millions
Biomerica Inc	6.15	$ 16.236 Millions	$ 3 Millions
Fonar Corporation	6.01	$ 13.952 Millions	$ 2 Millions
Inogen Inc	6.00	$ 202.903 Millions	$ 34 Millions
Evolus Inc	5.95	$ 58.351 Millions	$ 10 Millions
Carlisle Companies Incorporated	5.94	$ 4,336.300 Millions	$ 730 Millions
Patterson Companies Inc	5.94	$ 5,059.765 Millions	$ 852 Millions
Kaya Holdings Inc	5.86	$ 0.237 Millions	$ 0 Millions
Veracyte Inc	5.56	$ 72.289 Millions	$ 13 Millions
Avantor Inc	5.55	$ 4,989.200 Millions	$ 899 Millions
Logicmark Inc	5.49	$ 5.235 Millions	$ 1 Millions
Sunwin Stevia International Inc.	5.39	$ 29.273 Millions	$ 5 Millions
Abbvie Inc	5.33	$ 17,564.000 Millions	$ 3,295 Millions
Integer Holdings Corporation	5.31	$ 973.732 Millions	$ 183 Millions
Ufp Technologies Inc	5.28	$ 238.842 Millions	$ 45 Millions
Collegium Pharmaceutical Inc	5.16	$ 309.749 Millions	$ 60 Millions
Nexgel Inc	5.11	$ 1.727 Millions	$ 0 Millions
Harrow Inc	5.11	$ 24.298 Millions	$ 5 Millions
Lftd Partners Inc	5.05	$ 33.003 Millions	$ 7 Millions

Date modified: 2026-08-29T17:19:40+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.